A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma

Name: A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma
Published: 2018
License: Public Domain

Memorial Sloan Kettering Cancer Center · 2018

ClinicalTrials.gov · Datasets · License: Public Domain · 2018

Open Source ↗

nivolumab

advanced or metastatic non-clear cell renal cell carcinoma, unclassified renal cell carcinoma, papillary renal cell carcinoma, fumarate hydratase deficient renal cell carcinoma, succinate dehydrogenase deficient renal cell carcinoma, collecting duct renal cell carcinoma, chromophobe renal cell carcinoma, nivolumab, cabozantinib, 18-254, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma

Related documents